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ABSTRACT
Between July 2002 and July 2004, all male patients (n = 307) presenting to a sexually transmitted disease
(STD) clinic who reported unprotected sex were enrolled in the study. Of these, 63 (20.5%), 19 (6.2%)
and one (0.3%) were infected with one, two and three pathogens, respectively. The prevalences of
chlamydial infection, gonorrhoea, syphilis, human immunodeficiency virus infection and trichomoniasis
were 14.3%, 10.1%, 6.8%, 2.2% and 0%, respectively. The sensitivities of urethral discharge syndrome
for detection of chlamydial, gonococcal, and combined forms of infection were 31.8%, 58.5% and 70.0%,
respectively, with specificities of 93.5%, 97.1% and 93.9%, respectively. Positive predictive values
(PPVs) were 56.0%, 68.0% and 28.0% for chlamydial and gonococcal infections and combinations of the
two forms, respectively. In contrast, the sensitivity of genital ulceration syndrome for syphilis detection
was only 38.0%, although the specificity was 82.5%, and the PPV was 32.0%. To reduce the number of
false-positive results for STD patients who practise unprotected sex, incorporation of risk assessment
and rapid diagnostic tests are recommended.
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INTRODUCTION
Sexually transmitted diseases (STDs), including
disease caused by human immunodeficiency
virus (HIV), are associated with considerable
stigma, morbidity and mortality, and continue to
present major medical, social and economic prob-
lems worldwide [1]. Neisseria gonorrhoeae was
previously the most common STD pathogen;
however, its prevalence has declined in devel-
oped countries, and it accounts for only 20% of
the bacteria isolated from cases of urethritis in
recent studies [2–4]. The profile of STDs has
changed during the last 10 years because of a
rapid increase in non-gonococcal urethritis (NGU)
[5]. Chlamydia trachomatis is now the most com-
mon pathogen responsible for urethritis, and
accounts for 25–40% of cases [2]. In the USA,
c. 19 million individuals (with 25% aged
< 20 years) have been infected with one or more
STD pathogens [6]. However, despite the global
significance of STDs, relatively few epidemiolog-
ical studies have been undertaken.
Historically, interruption of the transmission of
STDs through diagnosis and treatment of infected
individuals has formed the cornerstone of public
health interventions [7]. Ideally, therapy for STDs
should be administered after aetiological diagno-
sis, at the time of initial clinical presentation.
However, in some settings, laboratory tests are
often not available because of a lack of laboratory
equipment or limited clinical training of laborat-
ory personnel. Consequently, syndromic criteria
have been used to provide a rational approach to
ensure prompt management of STDs [8]. The
syndromic approach, which has been promoted
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and implemented worldwide, has been a major
step towards improving management of these
infections in developing countries [9].
To design locally appropriate syndromic treat-
ment guidelines, it is important to have know-
ledge of the local STD aetiology and related
symptoms. The purpose of the present study was
to detail local clinical experience in Taiwan, to
investigate the prevalence and epidemiological
patterns specific to individual STD-causing patho-
gens, and to determine the performance of
syndromic case management and aetiological
diagnosis in the diagnosis and treatment of STDs.
MATERIALS AND METHODS
Setting
The STD clinic of the Taipei City STD Control Center is the
national referral centre and offers STD treatment to patients
living in the Taipei metropolitan area (population 2 300 000).
Some patients are referred by other healthcare providers, but
most attend on their own initiative, either for initial treatment
of an STD, or because therapy obtained elsewhere has failed.
Study population
From July 2002 to July 2004, new patients (aged > 18 years)
who attended the Taipei City STD Control Center clinic were
invited to participate in this study. Inclusion criteria were a
recent history of unprotected sex and no antibiotic use in the
preceding 30 days. Approval for the investigation was
obtained from the Institutional Review Board for the protec-
tion of human subjects at Taipei City STD Control Center,
Taipei, Taiwan. Patients who agreed to participate in the study
were asked to complete a questionnaire to determine relevant
socio-demographic characteristics, sexual behaviour and cur-
rent symptoms.
Following genital examination by a physician, blood sam-
ples were tested for Treponema pallidum and HIV antibodies.
Each participant provided a urine specimen that was tested for
N. gonorrhoeae, C. trachomatis and Trichomonas vaginalis.
Laboratory tests
Amplicor PCR tests for C. trachomatis ⁄N. gonorrhoeae (Roche
Diagnostic Systems, Branchburg, NJ, USA) were performed on
all individual samples according to the manufacturer’s
instructions for processing urine specimens [10]. To diagnose
Trich. vaginalis, wet-mount microscopy and culture in Whit-
tington media (HiMedia Laboratories, Mumbai, India) were
performed on urine specimens. Rapid Plasma Regain (RPR;
Spinreact, Girona, Spain) or the Venereal Disease Research
Laboratory (VDRL) test [11] was used for syphilis screening,
with confirmation by Trep. pallidum haemagglutination assay
(TPHA; Gesellschaft fur Biochemica und Diagnostica, Wies-
baden, Germany), following the manufacturer’s instructions.
Sera positive by both the RPR ⁄VDRL test (at 1:8 dilution) and
the TPHA test were considered to be indicative of active
syphilis. For HIV detection, double-ELISA tests (Biosign kits;
Princeton BioMeditech, Princeton, NJ, USA) and Western blot
assays (Genelabs Diagnostic, Redwood City, CA, USA) were
performed. All tests were conducted at the Taipei City STD
laboratory. Additional specimens from ten participants were
sent to the Taiwan Center for Disease Control (CDC, Taipei,
Taiwan) for repetition of some of the laboratory tests (RPR,
TPHA and PCR for gonorrhoea and chlamydial infection);
agreement between the results obtained by the two laborator-
ies was good (unpublished results).
Epi-Info v. 6.0 (CDC, Atlanta, GA, USA) was used for data
analysis. The chi-square ⁄ Fisher’s exact test and t-test were
used to analyse categorical and continuous variables, respect-
ively, with p £ 0.05 considered to be significant. The relative
proportions were calculated for various syndrome and disease
prevalences. The sensitivity, specificity, and positive predictive
value of the syndromic approach were determined using
laboratory test results as the reference.
RESULTS
Socio-demographic profile and prevalence of
laboratory-confirmed STDs
Between July 2002 and July 2004, 307 male
patients met the inclusion criteria and were
enrolled in the study. The age range was 16–
50 years (median 28.5) and most (52.1%) patients
were aged < 30 years (Table 1). Of the 307
patients, 83 (27.0%) were infected with at least
one pathogen, with 63 (20.5%), 19 (6.2%) and
one (0.3%) being infected with one, two and
three pathogens, respectively. The prevalences of
Table 1. Demographic characteristics and symptoms of
patients included in the study (July 2002 to June 2004,
Taipei, Taiwan)
Variables No. of patients (n = 307) %
Age group
< 20 9 2.9
20–29 151 49.2
30–39 102 33.2
40–49 33 10.7
‡ 50 12 3.9
Marital status
Single 210 68.4
Married 81 26.4
Divorced ⁄ separated ⁄widowed 16 5.2
Occupation
Business 89 29.0
Service 44 14.3
Student 52 16.9
Other 122 39.7
Sexual orientation
Heterosexual 270 87.9
Homosexual ⁄ bisexual 37 12.1
Prevalence rate of syndromes
Painful urination 44 14.3
Genital pain ⁄ swelling 42 13.7
Urethral discharge 34 11.1
Genital ulcer 33 10.7
Skin rash 29 9.4
Lower abdominal pain 7 2.3
No syndrome 154 50.2
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chlamydial infection, gonorrhoea, syphilis, HIV
infection and trichomoniasis were 14.3%, 10.1%,
6.8%, 2.2% and 0%, respectively (Table 2).
Prevalence and diagnostic efficacy of STD
syndromes
Of the 307 patients, 153 (49.8%) reported genito-
urinary symptoms, with 93, 40 and 20 cases
involving one, two or three symptoms, respect-
ively (Table 1). Of these symptomatic individuals,
50 were infected with at least one pathogen;
however, no pathogens were detected in 103
patients. Compared to the symptomatic cases,
there were lower rates of pathogen detection for
asymptomatic patients (32.7% vs. 21.4%; p <
0.026). The sensitivity, specificity and positive
predictive value of Taiwanese syndromic man-
agement guidelines for urethral discharge syn-
drome (UDS) and genital ulcer syndrome (GUS)
are summarised in Table 3.
DISCUSSION
Of the 307 patients in this study, 83 (27%) were
infected with at least one pathogen. The preva-
lences of C. trachomatis, N. gonorrhoeae, Trep.
pallidum, HIV and Trich. vaginalis infection were
14.3%, 10.1%, 6.8%, 2.2% and 0%, respectively,
for males attending the STD clinic. No pathogens
were detected in a high (73%) proportion of the
sample population, perhaps because > 50% (154 ⁄
307) of patients were asymptomatic. However,
21.4% (33 ⁄ 154) of the asymptomatic individuals
in this study who attended the STD clinic were
infected with at least one pathogen.
Evidence of gonococcal infection was detected
in 58% (18 ⁄ 31) of patients seeking treatment for
urethral discharge in Taipei. This is consistent
with other studies, in which N. gonorrhoeae was
found to be the aetiological agent in 53–80% of
urethritis cases in developed [12,13] and devel-
oping countries [14]. Concomitant C. trachomatis
infection was detected in 32% (10 ⁄ 31) of gono-
coccal urethritis cases in Taipei. This is compar-
able with other reports from developed countries,
in which 11–34% of patients with gonorrhoea
have been shown to be infected also with
C. trachomatis, which is the aetiological agent in
15–58% of cases of NGU [13,15]. Trich. vaginalis is
a common pathogen in male patients with ure-
thral discharge [16,17], with reported prevalences
of 14% and 22% in Malawi [14,17]; however,
Trich. vaginalis infection was not detected in the
present investigation.
HIV infection and syphilis affect similar patient
groups and co-infection is common [18]. Most
(5 ⁄ 6) HIV-positive patients in the present study
also had syphilis, which, like other ulcerative
STDs, is associated with enhanced sexual trans-
mission of HIV [19]. Recent outbreaks of syphilis
in the UK have raised serious concerns about the
sexual health of the population. Syphilis appears
more likely to facilitate HIV transmission than
any other sexually transmitted infection [20].
Since detection and treatment of syphilis can help
to reduce HIV propagation, a penicillin-based
regimen should be used for all HIV-positive
patients, and careful follow-up is required.
In western Europe, Mycoplasma genitalium has
been identified recently as an agent of NGU [21–
23], and M. genitalium is a more common cause of
NGU in Africa than C. trachomatis, being found
in 42% of patients with NGU [24]. However,
M. genitalium was not detected in the present
study.
It has been reported that syndromic manage-
ment protocols provide adequate treatment for
Table 2. Prevalence of STD pathogens among patients
(n = 307) attending the STD clinic, Taipei, Taiwan
Pathogens Number (%)
Chlamydia trachomatis only 34 (11.1)
Neisseria gonorrhoeae only 17 (5.5)
Treponema pallidum only 11 (3.6)
HIV only 1 (0.3)
Trichomonas vaginalis only 0 (0)
C. trachomatis + N. gonorrhoeae 9 (2.9)
HIV + Trep. pallidum 5 (1.6)
HIV + C. trachomatis 1 (0.3)
Trep. pallidum + N.gonorrhoeae 4 (1.3)
Trep. pallidum + C. trachomatis + N. gonorrhoeae 1 (0.3)
No pathogens detected 224 (73.0)
Total 307 (100.0)
STD, sexually transmitted disease; HIV, human immunodeficiency virus.
Table 3. Efficacy of syndrome-based diagnosis
Syndrome
No. of
patients
No. of
infected
patients
No of cases
detected by
syndrome
Sensitivity
(%)
Specificity
(%)
PPV
(%)
Urethral discharge
syndrome for:
Chlamydia 307 44 14 31.8 93.5 56.0
Gonococci 307 31 18 58.1 97.5 68.0
Gonococci
and Chlamydia
307 10 7 70.0 93.9 28.0
Genital ulcer
syndrome for:
Syphilis 307 21 8 38.0 82.5 32.0
PPV, positive predictive value.
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> 90% of patients with GUS [25], with the reported
positive predictive value of the syndromic
approach for N. gonorrhoeae infection and ⁄ or
chlamydial urethritis being between 75% and
97% in developing countries [26]. The principle
strength of the present study was in its relevance
for high-risk individuals, since the main patient
motivator for testing was recent unprotected sex.
Furthermore, the mixture of symptomatic and
asymptomatic men provided an opportunity to
measure the efficacy of empirical syndromic man-
agement of sexually transmitted infections. Over-
all, the false-negative rate for the UDS-based
syndromic management was c. 30–70% for cases
of genital infection involving gonococci or chla-
mydiae, or combined infections, and this approach
also resulted in false-positive results for 44%, 32%
and 72%, respectively, of UDS cases. Although the
specificity was higher for GUS (82.5%), syndromic
management based on this syndrome missed 62%
of active infections, leading to ulcer treatment in
the absence of syphilis in 68% of cases. This lack of
diagnostic efficacy imposes a financial burden
when treatment is unnecessary, and often
deprives asymptomatic individuals of therapeutic
intervention when it is required. Thus, even
though syndromic management of STDs has been
a major step towards improved treatment in
developing countries [9], the present study
revealed that its efficacy is limited in cases of
UDS and GUS. Incorporation of risk assessment
and rapid diagnostic tests can improve the effect-
iveness of syndromic management.
The investigation had several important lim-
itations. Only pathogens that were the target of
routine screening in hospitals, plus Chlamydia,
N. gonorrhoeae, Trep. pallidum, HIV and Tricho-
monas, were screened for in the laboratory. This
provided key data, but resulted in a missing
aetiology for nearly 70% of STD episodes. More
intense and costlier examinations for N. gonor-
rhoeae and a variety of other organisms causing
STDs are needed to complete the epidemiolog-
ical picture. In terms of the therapeutic setting,
the urban STD clinic may not adequately reflect
patient profiles at other urology and gynaeco-
logy hospitals ⁄ clinics. Furthermore, it is possible
that patients with severe STDs are less likely to
visit these specialist centres. This bias could be
corrected in future surveillance studies by
including selected local gynaecology and uro-
logy clinics and hospitals.
In conclusion, this study demonstrated that
the most frequent STD pathogens in Taipei are
C. trachomatis, N. gonorrhoeae and Trep. pallidum.
UDS and genital ulcers appear to be poor
predictors of aetiology in this setting. In order
to decrease the number of false-positive STD
treatments in patients compromised as a result
of unprotected sex, risk assessment and rapid
diagnostic tests should be incorporated where
necessary.
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